Fredun Pharmaceuticals Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Net Income	326.21	197.39	156.23	108.07	63.35
Depreciation & Amortization	82.47	49.14	37.42	27.65	21.33
Other Amortization	-	1.26	0.54	0.44	0.24
Other Operating Activities	399.75	303.08	187.99	155.43	79
Change in Accounts Receivable	844.36	-1,123	-302.89	557.13	-491.98
Change in Inventory	-299.16	-648.91	-248.74	-1,037	211.14
Change in Accounts Payable	-571.83	818.41	36.04	107.26	-113.44
Change in Income Taxes	24.25	15.81	12.45	-27.91	-5.45
Change in Other Net Operating Assets	346.5	95.92	116.57	-35.53	212
Operating Cash Flow	1,153	-290.63	-4.39	-144.09	-23.8
Capital Expenditures	-735.91	-61.06	-76.39	-94.95	-42.86
Sale of Property, Plant & Equipment	-	1.12	-	0.9	1.43
Investment in Securities	-	-3.6	-	-	-
Investing Cash Flow	-735.91	-63.54	-76.39	-94.05	-41.43
Short-Term Debt Issued	85.57	640.82	216.05	271.78	1.97
Long-Term Debt Issued	466.97	-	-	68.89	129.29
Total Debt Issued	552.54	640.82	216.05	340.67	131.25
Long-Term Debt Repaid	-	-24.45	-26.42	-	-
Total Debt Repaid	-	-24.45	-26.42	-	-
Net Debt Issued (Repaid)	552.54	616.37	189.63	340.67	131.25
Issuance of Common Stock	7.51	0.33	-	-	-
Other Financing Activities	-379.11	-225.53	-129.7	-88.9	-56.58
Financing Cash Flow	180.94	391.16	59.93	251.77	74.67
Miscellaneous Cash Flow Adjustments	-0	0	-0	-0	-
Net Cash Flow	597.58	36.99	-20.85	13.63	9.44
Free Cash Flow	416.64	-351.69	-80.78	-239.03	-66.66
Free Cash Flow Margin	6.52%	-7.75%	-2.32%	-8.70%	-2.97%
Free Cash Flow Per Share	78.20	-75.76	-17.40	-53.38	-16.05
Cash Interest Paid	-	223.77	136.5	92.82	46.69
Levered Free Cash Flow	-856.88	-551.15	-269.38	-445.24	-337.49
Unlevered Free Cash Flow	-611.27	-423.5	-191.14	-397.98	-310.05
Change in Working Capital	344.12	-841.49	-386.57	-435.68	-187.73

Source: S&P Global Market Intelligence. Standard template. Financial Sources.